Uncategorized

Some physicians may be overusing an invasive vascular procedure for patients with mild disease — making millions in the process, a ProPublica investigation into CMS data found.

Adolph "Dolph" Hutter Jr., MD, a globally renowned cardiologist and former director of Massachusetts General Hospital Heart Center's cardiac performance program, died Dec. 5 at 86 of natural causes.

A recent analysis found multiple myeloma patients in real-world settings have worse outcomes from standard regimens compared to those reported in clinical trials.

A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.

After bioprosthetic aortic valve replacement, patients who took the oral drug warfarin had better outcomes including lower mortality rates and fewer blood clots, according to new research from Rochester, Minn.-based Mayo Clinic.

First lady Jill Biden, EdD, will be visiting Los Angeles-based Cedars-Sinai Medical Center on Dec. 8, KNX News reported.

A Weill Cornell Medicine and NewYork-Presbyterian study found removing race information from cardiovascular risk calculators did not affect patients' risk scores.

With 16 cancer drugs currently on the FDA's drug shortage list, Jason Westin, MD, the director of Houston-based MD Anderson Cancer Center's Lymphoma Clinical Research Program, section chief for Aggressive Lymphoma, told the Senate Finance Committee Dec. 5 that "providers…

Atlanta-based Piedmont Oncology Institute named Walter Curran Jr., MD, its new chief.

Doris Ranski-Zazula, BSN, RN, was appointed vice president of the Detroit-based Karmanos Cancer Network, part of McLaren Health Care.